Clinical factors and the role of Wnt regulators in racial disparity of metastatic colorectal cancer survival.
Lists
Only you see this
Abstract
6551 Background: African American (AA) colorectal cancer (CRC) patients experience lower survival compared to Caucasian Americans (CA). Aberrant Wnt/beta catenin (bcat) signaling is the hallmark of CRC pathogenesis, yet its contribution and that of its regulators to racial disparity remains elusive. Recently, Casitas B-lineage Lymphoma (c-Cbl) was identified as a suppressor of tumorigenic bcat. A negative correlation between them supports effective regulation of bcat by c-Cbl. We examined the contribution of baseline characteristics, treatment, and Wnt regulators on survival disparity in a cohort of metastatic CRC (mCRC) patients at a safety-net hospital (SNH) with a large AA population. Methods: Patients with mCRC between 2004-2014 at the largest SNH in New England were analyzed. Histologic analysis to quantify the amounts of bcat and c-Cbl was performed using a customized, color-based customized image segmentation pipeline. Results: Among 147 subjects with mCRC, 41.5% were AA, and 35.4% CA. Median survival from diagnosis was significantly lower in AA compared to non-AA (20.16 vs 25.68 months, p < 0.05). No significant differences were detected in: age, gender, Charlson Comorbidity index, tumor location, number of metastatic sites, tumor mutations (KRAS/BRAF/MSI), chemotherapy regimen, or use of biologics. There were no significant differences in number of cycles received, response rate, progression rate, or toxicity with 1st line chemotherapy. Although a negative correlation between bcat and c-Cbl was observed in AA, it was stronger in non-AA patients (Pearson correlation coefficient -0.81, 95% CI -0.93 to -0.55 for AA, and -0.87, 95% CI -0.93 to -0.77 for non-AA). Conclusions: Lower survival rates in AA mCRC patients could not simply be accounted by socioeconomic, clinical, mutation, or therapy-related parameters, thus raising the possibility of pathogenic mediators as potential contributors to the racial disparity. These data support a trend towards stronger negative correlation suggesting better control of bcat in non-AA patients. These hypothesis-generating observations may potentially explain lower survival in AA mCRC patients, although validation in a larger cohort is warranted.
BibTeX
@article{lee2016clinical,
author = {Shin Yin Lee and Ümit Tapan and Moshe Shashar and Jamaica Siwak and Qing Zhao and Vijaya B. Kolachalama and Jean Francis and Kevan L. Hartshorn and Vipul C. Chitalia},
title = {{Clinical factors and the role of Wnt regulators in racial disparity of metastatic colorectal cancer survival.}},
journal = {Journal of Clinical Oncology},
year = {2016},
doi = {10.1200/jco.2016.34.15\_suppl.6551},
}Loading related content...